Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Vertex Pharmaceuticals Incorporated”

980 pharma patents match "Vertex Pharmaceuticals Incorporated" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 980
Index total 30,257
Page 37 / 41

Quick answer

This filtered view shows 980 pharmaceutical patents matching "Vertex Pharmaceuticals Incorporated" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

980 results for “Vertex Pharmaceuticals Incorporated” · 30,257 patents in full index Clear search

  1. US 7056944

    Pyrazole compositions useful as inhibitors of erk

    Vertex Pharmaceuticals Incorporated · Granted Jun 6, 2006 · Expires Jun 1, 2026

    granted
  2. US 7053057

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted May 30, 2006 · Expires May 25, 2026

    granted
  3. US 7041687

    Indazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted May 9, 2006 · Expires May 4, 2026

    expired
  4. US 7008948

    Fused pyrimidyl pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Mar 7, 2006 · Expires Mar 2, 2026

    expired
  5. US 6994868

    Compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired
  6. US 6995141

    Interleukin 1β protease and interleukin 1β protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired
  7. US 6995261

    4-pyridazinecarboxamides and esters as interleukin-1β converting enzyme inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Feb 7, 2006 · Expires Feb 2, 2026

    expired
  8. US 6989385

    Pyrazole compounds useful as protein kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 24, 2006 · Expires Jan 19, 2026

    expired
  9. US 6974809

    Inhibitors of interleukin 1-β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Dec 13, 2005 · Expires Dec 8, 2025

    expired
  10. US 6967214

    Inhibitors of IMPDH enzyme

    Vertex Pharmaceuticals Incorporated · Granted Nov 22, 2005 · Expires Nov 17, 2025

    expired
  11. US 6962936

    Triazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Nov 8, 2005 · Expires Nov 3, 2025

    expired
  12. US 6962996

    Inhibitors of p38

    Vertex Pharmaceuticals Incorporated · Granted Nov 8, 2005 · Expires Nov 3, 2025

    expired
  13. US 6949544

    Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Sep 27, 2005 · Expires Sep 22, 2025

    expired
  14. US 6949580

    Pyrazole compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Sep 27, 2005 · Expires Sep 22, 2025

    expired
  15. US 6930116

    Gyrase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Aug 16, 2005 · Expires Aug 11, 2025

    expired
  16. US 6916798

    Inhibitors of GSK-3 and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Jul 12, 2005 · Expires Jul 7, 2025

    expired
  17. US 6909000

    Bridged bicyclic serine protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jun 21, 2005 · Expires Jun 16, 2025

    expired
  18. US 6884804

    Inhibitors of Src and other protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Apr 26, 2005 · Expires Apr 21, 2025

    expired
  19. US 6878728

    Inhibitors of aspartyl protease

    Vertex Pharmaceuticals Incorporated · Granted Apr 12, 2005 · Expires Apr 7, 2025

    expired
  20. US 6875789

    Pyrazole-derived kinase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Apr 5, 2005 · Expires Mar 31, 2025

    expired
  21. US 6849267

    Compositions useful as inhibitors of ERK

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2005 · Expires Jan 27, 2025

    expired
  22. US 6849630

    Cyclized amino acid derivatives

    Vertex Pharmaceuticals Incorporated · Granted Feb 1, 2005 · Expires Jan 27, 2025

    expired
  23. US 6846928

    Compositions useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jan 25, 2005 · Expires Jan 20, 2025

    expired
  24. US 6838474

    Sulphonamide derivatives as prodrugs of aspartyl protease inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jan 4, 2005 · Expires Dec 30, 2024

    expired